Blue Trust Inc’s Pediatrix Medical MD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$58.8K Buy
2,320
+648
+39% +$14.7K ﹤0.01% 1283
2026
Q1
$35.8K Sell
1,672
-48
-3% -$999 ﹤0.01% 1456
2025
Q4
$36.8K Buy
+1,720
New +$35.2K ﹤0.01% 1464
2025
Q2
Sell
-368
Closed -$5.33K 2552
2025
Q1
$5.33K Hold
368
﹤0.01% 2096
2024
Q4
$4.83K Buy
368
+192
+109% +$2.65K ﹤0.01% 2092
2024
Q3
$1.33K Sell
176
-84
-32% -$792 ﹤0.01% 2663
2024
Q2
$2.61K Buy
260
+159
+157% +$1.31K ﹤0.01% 2379
2024
Q1
$1.01K Sell
101
-108
-52% -$1K ﹤0.01% 1946
2023
Q4
$2K Buy
209
+108
+107% +$1.12K ﹤0.01% 2171
2023
Q3
$1K Sell
101
-10
-9% -$137 ﹤0.01% 1934
2023
Q2
$2K Sell
111
-1,827
-94% -$25.7K ﹤0.01% 1730
2023
Q1
$29K Buy
1,938
+942
+95% +$14.3K ﹤0.01% 1242
2022
Q4
$17K Buy
996
+123
+14% +$2.01K ﹤0.01% 1349
2022
Q3
$18K Buy
873
+598
+217% +$12K ﹤0.01% 1134
2022
Q2
$6K Buy
+275
New +$5.61K ﹤0.01% 1388

Other funds holding MD

Blue Trust Inc's MD Position: Q2 2026 in Review

Blue Trust Inc increased its Pediatrix Medical (MD) stake by 39% in Q2 2026, buying an estimated $14.7K and bringing the position to 2,320 shares worth $58.8K. The position accounts for ﹤0.01% of the portfolio, ranked #1283.

Blue Trust Inc first reported a position in MD in Q2 2022 and has held it in 15 quarters since. 304 funds tracked by Wall St. Rank hold MD as of Q2 2026.

  • Blue Trust Inc held 2,320 shares of Pediatrix Medical worth $58.8K as of Q2 2026.
  • Blue Trust Inc bought 648 Pediatrix Medical shares in Q2 2026, an estimated $14.7K.
  • Pediatrix Medical made up ﹤0.01% of Blue Trust Inc's portfolio in Q2 2026, its #1283 holding.
  • Blue Trust Inc first reported a position in Pediatrix Medical in Q2 2022 and has held it in 15 quarters since.
  • 304 funds tracked by Wall St. Rank held Pediatrix Medical as of Q2 2026.

Based on Blue Trust Inc's 13F filing for Q2 2026, filed 21 Jul 2026.